These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Cancerogenic activity of antimitotic agents in animals]. Mazue G; Combes M Bull Cancer; 1983; 70(1):26-30. PubMed ID: 6839031 [TBL] [Abstract][Full Text] [Related]
3. Carcinogenicity of anticancer drugs and especially alkylating agents. Schmähl D IARC Sci Publ; 1986; (78):29-35. PubMed ID: 3583394 [No Abstract] [Full Text] [Related]
4. [Toxicology in cancer research. II. Cancerogenic drugs]. Schmähl D Dtsch Med Wochenschr; 1977 Jul; 102(29):1047-50. PubMed ID: 891377 [No Abstract] [Full Text] [Related]
5. Aspects concerning the study of the quantitative carcinogenic effects of chemotherapeutic agents in man. Kaldor JM; Day NE IARC Sci Publ; 1986; (70):327-35. PubMed ID: 3793182 [TBL] [Abstract][Full Text] [Related]
7. Epidemiological studies of anticancer drug carcinogenicity. Kaldor JM; Day NE; Shiboski S IARC Sci Publ; 1986; (78):189-201. PubMed ID: 3583390 [TBL] [Abstract][Full Text] [Related]
8. [Method of studying the potential carcinogenic properties of food products]. Neĭman IM; Kozlova IN Vopr Pitan; 1980; (1):58-61. PubMed ID: 7376557 [TBL] [Abstract][Full Text] [Related]
9. The dose-response effect: a critical analysis. Amadori S Bone Marrow Transplant; 1991; 7 Suppl 2():154-6. PubMed ID: 1878690 [No Abstract] [Full Text] [Related]
10. Cancer dose-response models. Sielken RL; Smith LA Dev Toxicol Environ Sci; 1983; 11():173-80. PubMed ID: 6677454 [No Abstract] [Full Text] [Related]
11. [The significance of the dosage strength in the response to cytotoxic drugs]. Rodríguez Díaz-Pavón J; Cabanillas F Med Clin (Barc); 1991 Mar; 96(10):374-6. PubMed ID: 2046414 [No Abstract] [Full Text] [Related]
12. Toxic factors limiting the use of anticancer agents. Hottendorf GH Chemioterapia; 1985 Oct; 4(5):383-7. PubMed ID: 4075433 [TBL] [Abstract][Full Text] [Related]
13. Possible hazards of working with cytotoxic agents: a review of the literature. Gross J; Johnson BL; Bertino JR Oncol Nurs Forum; 1981; 8(4):10-2. PubMed ID: 6913042 [No Abstract] [Full Text] [Related]
14. [Problem of the cancerogenicity of cytostatics]. Hartwich G; Butzler W Minerva Med; 1972 Apr; 63(31):1786-8. PubMed ID: 5025176 [No Abstract] [Full Text] [Related]
15. [Methods for optimizing cytostatic drug therapy]. Lipp HP Med Monatsschr Pharm; 1995 Oct; 18(10):282-91. PubMed ID: 7476654 [No Abstract] [Full Text] [Related]
16. [Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents]. Schmähl D; Osswald H Arzneimittelforschung; 1970 Oct; 20(10):1461-7. PubMed ID: 5536412 [No Abstract] [Full Text] [Related]
17. [High-dose chemotherapy for tumor treatment: the end of the beginning ?]. Bay JO; Blay JY Bull Cancer; 2001 Sep; 88(9):821. PubMed ID: 11604351 [No Abstract] [Full Text] [Related]